B

BioInvent International AB
STO:BINV

Watchlist Manager
BioInvent International AB
STO:BINV
Watchlist
Price: 29.3 SEK Market Closed
Market Cap: 1.9B SEK

Operating Margin
BioInvent International AB

-1 054.6%
Current
-577%
Average
-5.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 054.6%
=
Operating Profit
-471.2m
/
Revenue
44.7m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
SE
BioInvent International AB
STO:BINV
1.9B SEK
-1 055%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
343.7B USD
29%
US
Amgen Inc
NASDAQ:AMGN
155.1B USD
22%
US
Gilead Sciences Inc
NASDAQ:GILD
132.4B USD
38%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
129.8B USD
40%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
AU
CSL Ltd
ASX:CSL
118.8B AUD
26%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
61.2B USD
30%
US
Seagen Inc
F:SGT
39.3B EUR
-33%
NL
argenx SE
XBRU:ARGX
33B EUR
-1%

BioInvent International AB
Glance View

Market Cap
1.9B SEK
Industry
Biotechnology

BioInvent International AB engages in the research and development of novel and immuno-modulatory antibodies for the treatment of cancer. The company is headquartered in Lund, Skane and currently employs 84 full-time employees. The company went IPO on 2001-06-12. The Company’s operational activities are focused on expanding the clinical development of human antibodies, such as BI-1206, BI-1808, BI-1607 and BT-001. The firm has one wholly-owned subsidiary BioInvent Finans AB, which engaged in the administration of warrants issued by the Company.

BINV Intrinsic Value
84.73 SEK
Undervaluation 65%
Intrinsic Value
Price
B
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1 054.6%
=
Operating Profit
-471.2m
/
Revenue
44.7m
What is the Operating Margin of BioInvent International AB?

Based on BioInvent International AB's most recent financial statements, the company has Operating Margin of -1 054.6%.

Back to Top